Commitments and Contingencies - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended
	Dec. 31, 2020	Mar. 31, 2022	Mar. 31, 2021
Lessee Lease Description [Line Items]
Lease expense		$ 45,000	$ 100,000
Operating lease, cash payments		$ 45,000	$ 50,000
Operating lease weighted-average remaining lease term		1 year 8 months 12 days
Operating lease weighted-average discount rate		3.30%
Patent infringement suit description		In accordance with the Hatch-Waxman Act, because GIAPREZA is a new chemical entity and the Company filed a complaint for patent infringement within 45 days of receipt of the Notice Letter, the FDA cannot approve Gland’s ANDA any earlier than 7.5 years from the approval of the GIAPREZA NDA unless the District Court finds that all of the asserted claims of the patents-in-suit are invalid, unenforceable and/or not infringed. The Company intends to vigorously enforce its intellectual property rights relating to GIAPREZA
Waltham Sublease
Lessee Lease Description [Line Items]
Expiration date	Nov. 30, 2023
Sublease rent per month	$ 15,000